| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/09/2009 | US20090176705 Modular platform for targeted therapeutic delivery |
| 07/09/2009 | US20090176698 Benzimidazolone Derivatives for the Treatment of Urinary Incontinence |
| 07/09/2009 | US20090176307 Compounds, Compositions and Methods |
| 07/09/2009 | US20090175969 Formulation for treating obesity and associated metabolic syndrome |
| 07/09/2009 | US20090175968 Dietary compositions for promoting brain health |
| 07/09/2009 | US20090175959 Controlled Release Solid Preparation |
| 07/09/2009 | US20090175957 Acidic composition |
| 07/09/2009 | US20090175952 Cefuroxime axetil granule and process for the preparation thereof |
| 07/09/2009 | US20090175951 Nanoparticulate compositions of immunosuppressive agents |
| 07/09/2009 | US20090175950 Pharmaceutical safety dosage forms |
| 07/09/2009 | US20090175945 Systems, Methods, and Formulations for Topically Treating Nail Fungal Infections and Nail Psoriasis |
| 07/09/2009 | US20090175942 Solid Dosage Form of Olmesartan Medoxomil And Amlodipine |
| 07/09/2009 | US20090175941 Tablet-form slow-release preparation for vertigo |
| 07/09/2009 | US20090175940 Solubilized ibuprofen |
| 07/09/2009 | US20090175939 Pharmaceutical compositions |
| 07/09/2009 | US20090175938 Controlled Release Flurbiprofen and Muscle Relaxant Combinations |
| 07/09/2009 | US20090175935 Pharmaceutical compositions of duloxetine |
| 07/09/2009 | US20090175934 Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same |
| 07/09/2009 | US20090175933 Preparation for the treatment of diarrhoea |
| 07/09/2009 | US20090175930 Composition Suppressing The Expression of Target Gene in Eyeball and Medicament For Treating of Disease in Eyeball |
| 07/09/2009 | US20090175929 Transdermally absorbable Donepezil Preparation |
| 07/09/2009 | US20090175928 Lip Plaster |
| 07/09/2009 | US20090175925 Passive time released solute treatment |
| 07/09/2009 | US20090175924 Coated stent |
| 07/09/2009 | US20090175914 Salts or Complexes of Methyl Donors With Phytic Acid or Its Derivatives and Method for the Synthesis Thereof |
| 07/09/2009 | US20090175910 Modifications of HIV Env, Gag, and Pol enhance immunogenicity for genetic immunization |
| 07/09/2009 | US20090175908 Influenza Hemagglutinin And Neuraminidase Variants |
| 07/09/2009 | US20090175905 Transfection reagent and method for enhancing transfection efficiency |
| 07/09/2009 | US20090175892 Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes |
| 07/09/2009 | US20090175889 Hiv vaccine |
| 07/09/2009 | US20090175888 Methods of treating cancer with an antibody-drug conjugate |
| 07/09/2009 | US20090175882 Methods and compositions for treating hyperalgesia |
| 07/09/2009 | US20090175876 Methods of using phhla2 to co-stimulate t-cells |
| 07/09/2009 | US20090175872 Treatment of Conditions Involving Demyelination |
| 07/09/2009 | US20090175871 Method for demonstrating presence or absence of markers associated with the presence and/or the chemosensitivity of tumors |
| 07/09/2009 | US20090175869 Pulsatile Dosing of Gossypol for Treatment of Disease |
| 07/09/2009 | US20090175868 IGF-IR antagonists as adjuvants for treatment of prostate cancer |
| 07/09/2009 | US20090175859 TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease |
| 07/09/2009 | US20090175856 Anti-Proliferative Combination Therapy Using Certain Platinum-Based Chemotherapeutic Agents and EGFR Inhibitors or Pyrimidine Analogues |
| 07/09/2009 | US20090175852 Imidazopyrazines as protein kinase inhibitors |
| 07/09/2009 | US20090175849 NOTCH inhibition in the treatment or prevention of atherosclerosis |
| 07/09/2009 | US20090175848 Modulation of the Cooperativity Between the Ion Channels TRPM5 and TRPA1 |
| 07/09/2009 | US20090175846 Oligodendrocyte-Myelin Glycoprotein Compositions and Methods of Use Thereof |
| 07/09/2009 | US20090175845 Methods for identifying compounds that modulate phb domain protein activity and compositions thereof |
| 07/09/2009 | US20090175844 Method of diagnosing bladder cancer |
| 07/09/2009 | US20090175841 Compounds for Improving Nutritional Status, Cognition and Survival |
| 07/09/2009 | US20090175838 Methods of modulating immune function |
| 07/09/2009 | US20090175836 Prelamin a pre peptide as a universal stem cell differentiation signal |
| 07/09/2009 | US20090175827 miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
| 07/09/2009 | US20090175823 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist |
| 07/09/2009 | US20090175820 Inhibitors of cytochrome p450 |
| 07/09/2009 | US20090175818 Poly(Potassium and Sodium Styrene Sulfonate) Its Manufacture and Its Uses |
| 07/09/2009 | US20090175811 Use of compound that inactivates protein kinase a in a composition containing a cosmetically acceptable medium for lightening the skin |
| 07/09/2009 | US20090175810 Compositions and methods for treating diseases of the nail |
| 07/09/2009 | US20090175803 Method and compositions for administering resveratrol and pterostilbene |
| 07/09/2009 | US20090175802 Tiotropium containing hfc solution formulations |
| 07/09/2009 | US20090175801 Cns-tumor treatment method and composition |
| 07/09/2009 | US20090175800 Methods and Compositions For P2X Receptor Calcium Entry Channels and Other Calcium Entry Mechanisms |
| 07/09/2009 | US20090175796 Antibodies and related molecules that bind to 24p4c12 proteins |
| 07/09/2009 | US20090175795 Chimeric therapeutic agents |
| 07/09/2009 | US20090175794 Inhibitors of carbonic anhydrase ix |
| 07/09/2009 | US20090175793 Treatment of male sexual dysfunction |
| 07/09/2009 | US20090175792 Glycomimetic inhibitors of siglec-8 |
| 07/09/2009 | US20090175785 Self-Assembled Fmoc-Ff Hydrogels |
| 07/09/2009 | DE60019555C5 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit 2-oxy-benzoxazinonderivate for treatment of obesity |
| 07/09/2009 | CA2812705A1 Maleate, besylate, and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine |
| 07/09/2009 | CA2747008A1 Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7- dihydro-5h-pyrrolo[3,4-b]pyrazine |
| 07/09/2009 | CA2747000A1 Maleate, besylate, and l-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine |
| 07/09/2009 | CA2712358A1 Benzofuropyrimidinones as protein kinase inhibitors |
| 07/09/2009 | CA2711424A1 Novel lupane derivatives |
| 07/09/2009 | CA2711420A1 Novel c-21-keto lupane derivatives preparation and use thereof |
| 07/09/2009 | CA2711272A1 Quinazolines and related heterocyclic compounds, and their therapeutic use |
| 07/09/2009 | CA2711211A1 Oral pharmaceutical suspension comprising paracetamol and ibuprofen |
| 07/09/2009 | CA2711141A1 Hydroxy-bisphosphonic acid derivatives as vector for targeting bone tissue |
| 07/09/2009 | CA2711043A1 Method of synthesis of bosentan, its polymorphic forms and its salts |
| 07/09/2009 | CA2710977A1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs |
| 07/09/2009 | CA2710974A1 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | CA2710970A1 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | CA2710966A1 (20r)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | CA2710959A1 Imidazole carbonyl compounds and use thereof for treating bacterial infections |
| 07/09/2009 | CA2710954A1 (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | CA2710946A1 Substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
| 07/09/2009 | CA2710934A1 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof and medicinal products containing the derivative |
| 07/09/2009 | CA2710928A1 Parvovirus cancer therapy and combination with chemotherapy |
| 07/09/2009 | CA2710903A1 Carboxamide compounds and their use as calpain inhibitors |
| 07/09/2009 | CA2710832A1 Antiviral compounds |
| 07/09/2009 | CA2710786A1 Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives, and antifungal agents containing same |
| 07/09/2009 | CA2710764A1 Methods for enhancing muscle performance and tone |
| 07/09/2009 | CA2710743A1 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use |
| 07/09/2009 | CA2710740A1 Antitumor agent |
| 07/09/2009 | CA2710713A1 Silencing of polo-like kinase expression using interfering rna |
| 07/09/2009 | CA2710665A1 Treatment of heart disease using .beta.-blockers |
| 07/09/2009 | CA2710495A1 19-nor-steroid derivatives with a 15.alpha., 16.alpha.-methylene group and a saturated 17,17-spirolactone ring, use thereof and medicinal products containing these derivatives |
| 07/09/2009 | CA2710491A1 17-hydroxy-19-nor-21-carboxylic acid-steroid .gamma.-lactone derivative, use thereof and medicinal products containing the derivative |
| 07/09/2009 | CA2710486A1 15,16-methylene-17-(1'-propenyl)-17,3'-oxidoestra-4-en-3-one derivative, use thereof and drug containing the derivative |
| 07/09/2009 | CA2710477A1 Tetrasubstituted benzenes |
| 07/09/2009 | CA2710461A1 Benzimidazole compounds |
| 07/09/2009 | CA2710458A1 Imidazo [1,2-b] pyridazine compounds as modulators of liver x receptors |
| 07/09/2009 | CA2710454A1 Pyrazolo [1,5-a] pyrimidine compounds |
| 07/09/2009 | CA2710452A1 Imidazo [1,2-a] pyridine compounds |